Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

371

LikeLikedUnlike

Episodes 241-255 of 337

Supporting the Peripartum Period Through Perinatal Psychiatry
NeuroFrontiers
Supporting the Peripartum Period Through Perinatal Psychiatry
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Nichelle Haynes, DO
  Peer
Highlights from the 2023 Psych Congress
NeuroFrontiers
Highlights from the 2023 Psych Congress
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Craig Chepke, MD, FAPA
  Peer
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
NeuroFrontiers
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
Diagnosing Suspected MS: A Review of the Updated Guidelines
NeuroFrontiers
Diagnosing Suspected MS: A Review of the Updated Guidelines
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Eoin Flanagan, MB, BCh
  Peer
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
NeuroFrontiers
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
Locked Up in My Own Mind: Challenges in the Criminal Justice System
Psych Congress Action Center
Locked Up in My Own Mind: Challenges in the Criminal Justice System
advertisement
Clarity for Schizophrenia: The Latest in Drug Treatment
Psych Congress Action Center
Clarity for Schizophrenia: The Latest in Drug Treatment
New Drug Approved for PPD: Solving an Unmet Need
NeuroFrontiers
New Drug Approved for PPD: Solving an Unmet Need
Studying the Safety of Discontinuing DMTs in MS Older Adults
NeuroFrontiers
Studying the Safety of Discontinuing DMTs in MS Older Adults
- Andrew Wilner, MD, FACP, FAAN
  Peer
- John R. Corboy, MD
  Peer
Uncovering Disease Progression in Multiple Sclerosis
NeuroFrontiers
Uncovering Disease Progression in Multiple Sclerosis
- Sergio Baranzini, PhD
  Peer
Examining the Correlation Between HIV & Neurocognitive Disorders
NeuroFrontiers
Examining the Correlation Between HIV & Neurocognitive Disorders
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Santosh Kumar, PhD
  Peer
Prescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
NeuroFrontiers
Prescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Ashley Baker, MSN, PMHNP
  Peer
advertisement
NIH Study Identifies Cause for Long COVID Neurological Symptoms
NeuroFrontiers
NIH Study Identifies Cause for Long COVID Neurological Symptoms
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Avindra Nath, MD
  Peer
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
NeuroFrontiers
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Lokesh Shahani, MD, PhD, MPH, FACP, FASAM
  Peer
Combating Controversies in BPSD Care
NeuroFrontiers
Combating Controversies in BPSD Care
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Rajesh Rajagopalan Tampi, MBBS, MS, DFAPA
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended